DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
The ASAP Act amends Medicare to cover blood-based and other biomarker screening tests for early detection of Alzheimer's disease and related dementias, effective January 1, 2028. The bill defines eligible tests as those cleared, classified, or approved by the FDA, including genomic sequencing blood tests, cell-free nucleic acid analysis, protein expression tests, and certain medical imaging based on biospecimens. Medicare payment for these screening tests would be established under the bill's payment provisions.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.